West Pharmaceutical Services | 3: Initial statement of beneficial ownership of securities-Director HAUGEN JANET BRUTSCHEA
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Director HAUGEN JANET BRUTSCHEA
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Officer Witherspoon Charles
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Officer Abraham Silji
West Pharmaceutical Services | 10-Q: Q3 2024 Earnings Report
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | S-8 POS: S-8 POS
West Pharmaceutical Services | S-8 POS: S-8 POS
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Officer Witherspoon Charles
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Director Hofmann Thomas W
West Pharmaceutical Services | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Green Eric Mark
West Pharmaceutical Services | 4: Statement of changes in beneficial ownership of securities-Officer Green Eric Mark
West Pharmaceutical Services | 144: Notice of proposed sale of securities pursuant to Rule 144
West Pharmaceutical Services | 10-Q: Q2 2024 Earnings Report
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | 8-K: Current report
West Pharmaceutical Services | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)